The NHS claims that it's been able to save taxpayers £1.2 billion in just three years by procuring hundreds of hospital medicines at a better price.
The adoption of cheaper versions of a single drug - adalimumab - which is used to treat more than 45,000 patients with rheumatoid arthritis, inflammatory bowel
disease and psoriasis, has accounted for about one third of the savings.
After the exclusive patent on the drug - originally known as its brand name Humira - expired in 2018, the NHS struck cost-saving deals to bulk-buy generic versions,
which have the same quality, safety and efficacy of a branded one.
Since then, tens of millions of pounds have been saved by buying cheaper generic versions of other medicines for conditions ranging from severe skin infections to
aggressive blood cancers.
Four in five medicines prescribed in the NHS are now non-branded, helping the NHS to achieve significant savings while ensuring the continuity of high-quality
patient care.
NHS chief executive Amanda Pritchard said: "Smart deals by the NHS mean patients are getting the best medicines and taxpayers are getting best value.
Charac, an NHS-integrated one-stop platform for independent community pharmacies, has secured £1 million strategic investment from the Royal Mail Group,
enabling its time-saving platform to assist more local pharmacies and patients across the UK to easily manage their prescriptions and consultations online.
The company said this new money will enable it to leverage strong levels of trust that pharmacists enjoy within the communities they serve in and will ensure
pharmacies remain a cornerstone of vibrant high streets and an invaluable provider of frontline healthcare products and services, including vitally needed
consultations.
Charac says it is aiming to sign up over 1,000 UK pharmacies in the next 12 months by expanding its geographic footprint beyond current cities, including London,
Manchester and Birmingham, and targeting small multiple and independent pharmacies, accounting for almost 40 per cent of the UK's community pharmacy network.
The announcement also sees the addition of Stefan Kulik, a managing director at Royal Mail, to the Charac board. Stefan is responsible for leading Royal Mail's
expansion into the healthcare industry and brings a breadth of experience, having previously worked in healthcare with companies including Johnson & Johnson.
The Royal Pharmaceutical Society (RPS) has appointed Neville Carter as its new chief education and membership officer.
Neville joins RPS from the Royal Society of Medicine (RSM) where he is currently director of engagement, leading a team of over 60 and responsible for creating a
combined directorate accountable for education, membership, philanthropy, and business development.
He has, in particular, led on the development of a digital education strategy and launched professional development training programmes for members.
Prior to joining the RSM, Neville worked as director of product and sales at the British Medical Association with responsibility for membership growth, supporting
corporate transformation and developing and managing member benefits and relationships with third-party providers to support revenue growth. He also has senior
manager experience at the RAC and at British Airways.
Commenting on the appointment, Paul Bennett, RPS CEO, said: "I'm delighted that Neville will be joining our Executive team. He brings a wealth of relevant experience
and this, in combination with a strong existing education and membership team at RPS and a clear ambition to strengthen the relevant functions further, will enable
the organisation to deliver a dynamic offering for our members.
Are you feeling overwhelmed about the MCAT? You're not alone! The MCAT is a challenging test that can feel daunting for even the best students. But don't worry,
this article is here to help. This blog post will discuss six clever strategies that will help you pass the MCAT successfully. Follow these tips and you'll be on
your way to achieving your dream score.
ENROLL IN A PREP COURSE
One of the first things you should do when preparing for the MCAT is to enroll in a prep course. Keep in mind that the right MCAT prep course will provide you with
the resources and support you need to succeed. Additionally, it can help to take practice tests under simulated testing conditions. This will help you get used to
the format of the test and reduce your anxiety on test day. In choosing a prep course, make sure to pick one that is reputable and has a good track record. You
should also make sure that the course is affordable and offers a schedule that fits your needs. If possible, you can also take practice tests that are offered by
the course. This way, you can get an idea of the type of questions that will be on the test.
JOIN A STUDY GROUP
Many people find that studying in a group is more effective than studying alone. When you join a study group, you'll have the opportunity to discuss difficult
concepts with your peers. Additionally, you'll be able to hold each other accountable and stay on track with your studies. If you're not sure where to find a
study group, ask your friends or classmates if they're interested in forming one. You can also check online forums or look for groups that have already been
established.
Pharmacists are a vital member of the multidisciplinary team (MDT) supporting older people to manage their pain. The pharmacist is uniquely positioned to
holistically review drug interactions and potential risks associated with each patient's medication and has the expertise to suggest alternative treatment options
to reduce the risks associated with polypharmacy or unwanted side effects caused by other medications.
Chronic pain
The International Association for the Study of Pain defines pain as an unpleasant sensory and emotional experience associated with, or resembling that associated
with, actual or potential tissue damage.
Although universally experienced by everyone, the perception of pain is a deeply personal experience influenced by biological, psychological, and social factors, and
constitutes an essential behavioural feedback mechanism aimed at protecting us from harm.
Pain may be perceived as either acute or chronic. Chronic pain, defined as pain that persists longer than the normal healing time, constitutes a substantial
healthcare burden, affecting approximately 20 per cent of people worldwide and accounts for 15-20 per cent of physician consultations.
Chronic pain is often associated with disrupted mood and sleep, substance misuse and other chronic conditions. Additionally, comorbidities of chronic pain may also
lead to complex medication regimens that increase the risks of adverse drug interactions and unwanted side effects.
The UK government will lay legislation today (13 December 2023) to allow the General Medical Council (GMC) to begin the process of regulating medical
associates to expand their roles in the NHS.
This will support plans to reduce pressure on doctors and GPs and improve access for patients, the Department of Health and Social Care (DHSC) said.
Physician associates (PAs) and anaesthesia associates (AAs) will have the same levels of regulatory oversight and accountability as doctors and other regulated
healthcare professionals once the regulations come into force, which is expected at the end of 2024.
The GMC will design and deliver detailed regulatory processes for registration, education, standards and fitness to practise for both professions.
Representatives for prescribers across Scotland, politicians, academics and clinicians gathered to discuss the importance of environmental sustainability
in healthcare during a Scottish Parliamentary reception held at Holyrood on Wednesday (13 December).
Royal Pharmaceutical Society (RPS) informed the parliament that medicines account for around 25 per cent of carbon emissions across the NHS, while highlighting
the various innovative ways to reduce these carbon emissions.
The NHS in Scotland needs to implement effective environmentally sustainable approaches to healthcare in order to meet its ambition to achieve net zero, RPS
pointed out.
Laura Wilson, Director for Scotland at RPS, said: "It was fantastic to bring together pharmacists, parliamentarians and partners from across government and
healthcare to highlight the huge opportunity which exists in healthcare to make our systems and processes more environmentally sustainable.
There were an estimated 408,700 hospital admissions due to smoking in 2022-23, an increase of 4.8 per cent from 389,800 in 2021-22, latest statistics
published by NHS England have shown.
In 2020-21, there were 314,100 admissions attributed to smoking, which was consistent with fewer hospital admissions overall that year, according to the
health service's Statistics on Public Health, 2023 report.
However, smoking-related admissions in each of the past three years remained lower than in 2019-20, prior to the Covid pandemic, when there were 446,400 cases.
Smoking accounted for around one in six (16 per cent) of all hospital admissions for respiratory diseases last year, eight per cent of all admissions for cancers
and seven percent of admissions for cardiovascular diseases.
Two weeks prior to the closing of the hub and spoke consultation, issues around patient safety, costs and competition as well as practicalities such as what
to do with uncollected medicines were discussed in a webinar on hub and spoke dispensing on Wednesday (May 26).
The webinar was organised by Sigma Pharmaceuticals in association with the National Pharmacy Association (NPA).
NPA director of corporate affairs Gareth Jones chaired the event and was joined by Sigma's Hatul Shah and Raj Haria as well as NPA vice chair Nick Kaye and NPA
head of advice and support services Jasmine Shah.
Kaye said: "There are still many 'unknown unknowns' with hub and spoke and the jury's still out on any potential benefits. I have lots of reservations about cost
and it worries me how efficient this is for the business and the long term sustainability for the sector as a whole. Above all we need to think about the patient
at the centre of all this and the potential confusion for them."
Jasmine Shah felt patient safety was going to be the key in regards to whether the spoke and the hub would hold the ultimate responsibility and "who is going to
take the accountability as far as patient care goes".
She added: "It is most important that GPhC standards and NHS requirement are both met in identifying all the risks associated with the arrangement with hub and
spoke and ensuring that (patient safety) measures are in place. Everything that needs to be looked at is by putting the patient at heart of the arrangement and
seeing what is the safest way for them to receive care from both spoke and hub."
There are several aspects that must be taken into account. There are instances where two different kinds of medicines lead to side effects, hence you must see how you are managing your medication. Let us have a look at some of the best methods to ascertain proper medication management:
LEARN ABOUT MOST COMMON MEDICATION MISTAKES
This is one of the first things that one should know about simply because when you know what can lead to mistakes, you do not make mistakes. Some of the mistakes that most patients make may be in the form of taking too much medication, mixing up home remedies with prescribed drugs, and non-adherence to medical requirements.
Evidence suggests that such mistakes lead to the ineffectiveness of medication, side effects, and overdose.
USE ORGANIZATION TOOLS
It may get very difficult to keep a track of the time and number of pills you need every day. It is especially true for elderly people who have a need for polypharmacy which is the use of five or more medications on a daily basis. Organization tools such as pill-box, alarm watch, and water bottle can be really helpful.
For example, a pill-box can be used to keep your medicines safely and separately as per their categories such as medicines for diabetes in one part and medicines for pain in the other. This would help you easily manage your medication routine without a miss.
Two new subvariants of Omicron - BA.4 and BA.5 - are spreading much faster than other corovanirus variants in Europe, which could lead to more hospitalisations
and deaths as they become dominant, the EU's disease prevention agency said on Monday (June 13).
Most EU countries have so far detected low rates of the two subgroups. But in countries where the proportion has risen - such as Portugal, where BA.5 accounted for
87 per cent of cases by May 30 - there have been surges in overall cases, according to the European Centre for Disease Prevention and Control (ECDC).
The two sublineages were added to the World Health Organization's monitoring list in March and have also been designated as variants of concern by the ECDC.
Variants BA.4 and BA.5 do not appear to carry a higher risk of severe disease than other forms of Omicron.But an increase in case numbers from higher transmission
rates risks leading to an increase in hospitalisations and deaths, the agency said.
"The growth advantage reported for BA.4 and BA.5 suggest that these variants will become dominant," ECDC said in a statement on its website.
Prostate cancer is the most common cancer among men in the United Kingdom, affecting nearly 50,000 men yearly. Combined with the challenges faced across
healthcare during COVID-19, new figures show that prostate cancer accounts for a third of cancers not treated due to the pandemic, with 14,000 'missing patients'
believed to have not undergone treatment since April 2020. It is more urgent than ever that men are encouraged to get checked, as any set-backs in diagnosis can
reduce the pathways available, in turn affecting health outcomes.
Community pharmacy teams play a crucial role in signposting the help available for men who may be concerned about their health. Therefore, it is vital that pharmacy
teams have access to the information they need to correctly direct men to seek prostate cancer guidance. By maximising the trusted relationship between patients and their pharmacists, more can be done to identify the warning signs, helping men to get an earlier diagnosis.
The Royal Pharmaceutical Society has appointed communications agency to lead a review into how it can develop and strengthen member participation.
"We've appointed communications consultancy Luther Pendragon to carry out an independent review of the participation of members and of our communications
concerning decisions we take on behalf of the profession through our Governance boards," the Society said in a statement on Tuesday (May 10).
It added that review would examine how RPS members, elected members and stakeholders can feel engaged, informed and empowered to influence decisions about RPS policy and understand why decisions around organisational policy have been taken on their behalf by elected representatives.
It will also ensure RPS decision-making processes are open and transparent with an emphasis on evidence-based decision making, and recommend ways elected members are enabled to be publicly accountable for decisions taken by the organisation at Board and Assembly level.
We have been specialising in community pharmacy sector for over 30 years and have helped many pharmacists acquire their first pharmacy. We have seen several
of those first-time buyers transition into multiple pharmacy owners under our specialist guidance and support through the years.
Acquiring the first pharmacy can be a challenge to most pharmacists especially when they do not have the necessary skill in reading the numbers presented in terms
of the target pharmacy's performance and how to interpret these in order to arrive at a valuation for the purpose of submitting an offer.
Without the guidance of a specialist accountant in community pharmacy, one of the major risks is that one could end up paying more than what the pharmacy is worth.
Once the offer is accepted, there are other challenges to overcome to get the deal over the line.
1) Assessing the risk
2) Valuation of the business
3) The negotiation process
4) Asset or company purchase
5) Financial due diligence
6) Asset/share purchase agreement
7) Finance the purchase
The National Pharmacy Association (NPA) has been in dialogue with the senior management of NHS Property Services to bring down the rent for community
pharmacies based in NHS health centres.
Association said: "Community pharmacies based in NHS health centres are struggling to make ends meet due to expensive rental rates."
It is calling for pharmacies to have the ability to renegotiate rental rates part way through a contract.
Gareth Jones, Director of Corporate Affairs at the NPA, said landlords need to take into account that pharmacy spending power is shrinking and the previous formula
used to set rental rates is no longer fit for purpose.
"It no longer makes sense to calculate based on historical assumptions about how many prescriptions the co-located GP will generate for the pharmacy," he said.
The National Pharmacy Association (NPA) highlighted the role played by community pharmacies during pandemic to provide urgent care and vital support to people
with long-term medical conditions at its opening remark in the Covid-19 public inquiry held on Tuesday (28 February).
NPA is the core participant in the Covid-19 public inquiry. lawyer Brian Stanton made an opening statement on the NPA's behalf which focused on three areas- health
inequalities and the needs of vulnerable patients; the impact of medicine shortages and medicine price increases and the challenge that community pharmacy faced in
responding to the pandemic and maintaining patient services following long-term under investment.
Stanton said: "The UK's community pharmacies were on the frontline of efforts to limit the impact of coronavirus and to keep people well, and as well as handling a
massive increase in demand for healthcare advice and medicines, they also continued to provide urgent care and vital support to people with long-term medical
conditions.
"However, there are now very many at risk of closure during to underfunding and when the Inquiry comes to consider its recommendations the NPA would encourage
you [the presiding judge] to think about how resilience can be built into future plans."
The statement included a compelling account of the commitment typical of so many pharmacies during the pandemic - from husband and wife Pete and Sukhi Johal, both
NPA members and pharmacists, who co-own Calow Pharmacy in Chesterfield.
Steve McCabe, the Labour MP for Birmingham, Selly Oak says a "vicious" NHS contract has been forcing community pharmacies into bankruptcy.
Asking his question in parliament during Prime Minister's Questions on Wednesday (March 8), McCabe said he has heard Rishi Sunak speak fondly about working in his
mother's community pharmacy.
The MP asked how would the prime minister feel "if 600 pharmacies close this year because of a vicious NHS contract which takes no account of rising costs and is
forcing many into bankruptcy?"
The prime minister responded by saying that community pharmacies do fantastic work and that his government was looking at ways in which it could support the sector
to do even more.
Sunak said: "I praise the work that our community pharmacies do. They are fantastic at being on the frontline of delivering primary care. And as I've said previously
the government is exploring ways in which we can support them to do even more.
Superdrug has announced a pay increase for newly qualified pharmacists, in a move that will see wages rise to £50,000 - ensuring that Superdrug Pharmacists
continue to receive the strongest renumeration package on the high street today.
Superdrug is also enhancing its patient experience and operational structure, with the introduction of a new role of Pharmacy Team Leader to selected pharmacy stores.
Pharmacy Team Leaders will be dispenser trained and provide a clear line of accountability for day-to-day dispensary activity including adhering to legal and
clinical frameworks whilst supporting, coaching, and developing a high-performing pharmacy team.
The role also allows Superdrug to offer a clear line of progression for talented Pharmacy Dispensers and Technicians who want to do more in their career and recognises
the valuable contribution Pharmacy Dispensers & Technicians play in community pharmacy.
In addition, the appointment of two new Heads of Pharmacy Operations sees the high street retailer driving and improving Superdrug's pharmacy performance to offer the
best possible care for patients. Craig Watt, Pharmacist and previously Area Manager, has been appointed to Head of Pharmacy Operations North and will be responsible
for the operation of Superdrug's central distribution hub serving its e-pharmacy and Online Dr team.
The recruitment of pharmacists in Primary Care Networks (PCNs) has exacerbated a general shortage of pharmacists, revealed an independent review of Integrated
Care Systems (ICSs) published on Tuesday (4 April).
The review, Rt Hon Patricia Hewitt, highlighted the impact that the Additional Roles Reimbursement Scheme (ARRS) roles for pharmacists are having on the community
pharmacy sector.
"Contracts with national requirements can have unintended consequences when applied to particular circumstances. For instance, the national requirements and funding
of Additional Roles Reimbursement Scheme (ARRS) roles for community pharmacists within PCNs, has on occasion exacerbated the problem of a general shortage of
pharmacists, with some now preferring to work within primary care rather than remain in community pharmacies or acute hospitals, compounding the problem of community
pharmacy closures and delayed discharges."
It set out to consider the oversight and governance of ICS in England and the NHS targets and priorities for which Integrated Care Boards (ICBs) are accountable,
including those set out in the Government's mandate to NHS England.
As part of this work, Hewitt and her team engaged with a wide range of stakeholders representing various local health and social care settings, including LPCs.
Titan PMR has been accredited by the NHS to provide electronic prescription services (EPS) to dispensing doctors.
Over 1,000 of these doctors, who provide a vital service to almost 10 million people in rural communities, can now offer their patients the same level of benefits
and efficiencies that electronic prescriptions and Titan PMR have brought to pharmacies around the UK.
These features will also increase efficiency for dispensing doctors, who will reduce dispensing errors and improve organisation, increasing their capacity while
enjoying the ability to integrate with other technologies.
After a full year of testing, including six months of compliance testing at a practice in Cumbria, the new accreditation for Titan also has potential to help the
NHS fulfil its target of all prescriptions being issued electronically.
Currently written paper prescriptions from dispensing doctors account for around seven per cent of the total prescriptions in England - around 6.5 million each month.
"Until now dispensing doctor surgeries have basically been in the digital dark ages when it comes to dispensing medicines," said Tariq Muhammad, a tech entrepreneur
and CEO of Bristol-based Invatech Health, which developed Titan PMR.